REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/14/2026
Back to search
Official data from USPTO
Q THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/14/2026
Trademark type
Combined
Nice classes
1, 42
Filing date
05/07/2004
Registration date
08/14/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2017
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/30/2007
First use in commerce
01/30/2007
Drawing code
5
Owner type
03
Owner location
Salt Lake City, UT, US
Examiner
DUBOIS, SUSAN L
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Q Therapeutics, Inc.
Representatives
Kathleen A. Tyrrell Licata & Tyrrell P.C.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientificlaboratory or medical research
Class 42
Licensing of intellectual propertynamely technology used in the development and manufacture of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
38 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/20/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/20/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/20/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/20/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
08/14/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/14/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/28/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2012
E815
TEAS SECTION 8 & 15 RECEIVED
09/21/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
08/14/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/09/2007
ALIE
ASSIGNED TO LIE
07/06/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/04/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/25/2007
IUAF
USE AMENDMENT FILED
02/05/2007
EISU
TEAS STATEMENT OF USE RECEIVED
02/05/2007
EX2G
SOU EXTENSION 2 GRANTED
09/20/2006
EXT2
SOU EXTENSION 2 FILED
09/20/2006
EEXT
SOU TEAS EXTENSION RECEIVED
09/20/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/20/2006
EX1G
SOU EXTENSION 1 GRANTED
03/20/2006
EXT1
SOU EXTENSION 1 FILED
03/20/2006
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/20/2005
PUBO
PUBLISHED FOR OPPOSITION
06/28/2005
NPUB
NOTICE OF PUBLICATION
06/08/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2005
ALIE
ASSIGNED TO LIE
03/18/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2005
GNRT
NON-FINAL ACTION E-MAILED
12/08/2004
CNRT
NON-FINAL ACTION WRITTEN
12/08/2004
DOCK
ASSIGNED TO EXAMINER
12/07/2004
NWAP
NEW APPLICATION ENTERED
05/14/2004
Continuous trademark protection
Get notified about every new filing that threatens Q THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.